Jean George's Net Worth

$150 Million

Estimate Recalculated Jul 15, 2024 03:08PM EST

Who is Jean George?

Jean George has an estimated net worth of $150 Million. This is based on reported shares across multiple companies, which include Zeltiq Aesthetics Inc, ALX ONCOLOGY HOLDINGS INC, Cyteir Therapeutics, Inc., Gemini Therapeutics, Inc. /DE, Calithera Biosciences, Inc., CATABASIS PHARMACEUTICALS INC, CRITICAL THERAPEUTICS INC, ACCELERON PHARMA INC, and PORTOLA PHARMACEUTICALS INC.

SEC CIK

Jean George's CIK is 0001291804

Past Insider Trading and Trends

2015 was Jean George's most active year for acquiring shares with 15 total transactions. Jean George's most active month to acquire stocks was the month of May. 2021 was Jean George's most active year for disposing of shares, totalling 30 transactions. Jean George's most active month to dispose stocks was the month of November. 2020 saw Jean George paying a total of $7,600,000.00 for 4,120,733 shares, this is the most they've acquired in one year. In 2013 Jean George cashed out on 7,987,387 shares for a total of $49,185,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Zeltiq Aesthetics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.81%
790
—
—
5.79K
Jul 22
Form 4
∞
5K
—
—
5K
Jun 17
Form 4
—
0
$17.78
-$401,410.30
0
Scheduled
Jan 15
Form 4
—
0
$15.54
-$335,907.69
0
Scheduled
Nov 3
Form 4
-100.00%
-29.16K
$20.09
-$585,778.71
0
Jul 31
Form 4
—
0
—
—
0
May 30
Form 4
-51.60%
-2.00M
$22.62
-$702,942.24
1.88M
Jan 17 - Jan 21
Form 4
-50.94%
-4.03M
$12.22
-$49,185,500.00
3.88M
Nov 14
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 14
Form 3
—
0
—
—
0
No matching records found

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.99%
-48.39K
$26.61
-$1,287,431.32
2.38M
Dec 13
Form 4
-5.65%
-145.64K
$32.26
-$4,698,091.14
2.43M
Dec 8 - Dec 10
Form 4
+397.27%
4.09M
$19.00
$7,600,000.00
5.12M
Jul 21
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Cyteir Therapeutics, Inc. (CYT) Snapshot price: $3.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
14.15K
$1.69
$23,913.50
14.15K
Feb 14
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Feb 22
Form 4
∞
2.44M
—
—
2.44M
Jun 22
Form 3
—
0
—
—
0
No matching records found

Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $66.42

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 9
Form 4
∞
2.11M
$10.00
—
2.11M
Oct 7
Form 3
—
0
—
—
0
No matching records found